US Bancorp’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

US Bancorp’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.31M	Hold	16,500	–	–	﹤0.01%	1033
2025 Q4	$1.36M	Hold	16,500	–	–	﹤0.01%	1031
2025 Q3	$1.15M	Hold	16,500	–	–	﹤0.01%	1076
2025 Q2	$1.06M	Hold	16,500	–	–	﹤0.01%	1091
2025 Q1	$1.05M	Hold	16,500	–	–	﹤0.01%	1091
2024 Q4	$1.1M	Hold	16,500	–	–	﹤0.01%	1087
2024 Q3	$1.15M	Sell	16,500 -300	-2%	-$20.8K	﹤0.01%	1070
2024 Q2	$1.09M	Hold	16,800	–	–	﹤0.01%	1064
2024 Q1	$1.09M	Buy	16,800 +300	+2%	+$19.5K	﹤0.01%	1079
2023 Q4	$1.09M	Hold	16,500	–	–	﹤0.01%	1070
2023 Q3	$941K	Hold	16,500	–	–	﹤0.01%	1090
2023 Q2	$1.01M	Hold	16,500	–	–	﹤0.01%	1067
2023 Q1	$1.04M	Hold	16,500	–	–	﹤0.01%	1061
2022 Q4	$1.05M	Hold	16,500	–	–	﹤0.01%	1041
2022 Q3	$973K	Sell	16,500 -465	-3%	-$28.7K	﹤0.01%	1069
2022 Q2	$980K	Hold	16,965	–	–	﹤0.01%	1104
2022 Q1	$1.05M	Hold	16,965	–	–	﹤0.01%	1157
2021 Q4	$1.21M	Hold	16,965	–	–	﹤0.01%	1122
2021 Q3	$1.27M	Hold	16,965	–	–	﹤0.01%	1072
2021 Q2	$1.31M	Hold	16,965	–	–	﹤0.01%	1064
2021 Q1	$1.25M	Hold	16,965	–	–	﹤0.01%	1040
2020 Q4	$1.19M	Hold	16,965	–	–	﹤0.01%	1022
2020 Q3	$961K	Sell	16,965 -5,500	-24%	-$323K	﹤0.01%	1019
2020 Q2	$1.31M	Hold	22,465	–	–	﹤0.01%	848
2020 Q1	$1.04M	Hold	22,465	–	–	﹤0.01%	891
2019 Q4	$1.25M	Hold	22,465	–	–	﹤0.01%	957
2019 Q3	$1.06M	Hold	22,465	–	–	﹤0.01%	1003
2019 Q2	$1.2M	Hold	22,465	–	–	﹤0.01%	998
2019 Q1	$1.24M	Hold	22,465	–	–	﹤0.01%	971
2018 Q4	$1.06M	Hold	22,465	–	–	﹤0.01%	982
2018 Q3	$1.34M	Hold	22,465	–	–	﹤0.01%	967
2018 Q2	$1.23M	Hold	22,465	–	–	﹤0.01%	1004
2018 Q1	$1.11M	Buy	22,465 +220	+1%	+$11.2K	﹤0.01%	1037
2017 Q4	$1.05M	Hold	22,245	–	–	﹤0.01%	1080
2017 Q3	$1.11M	Hold	22,245	–	–	﹤0.01%	1028
2017 Q2	$1.02M	Hold	22,245	–	–	﹤0.01%	1048
2017 Q1	$941K	Sell	22,245 -825	-4%	-$34.6K	﹤0.01%	1106
2016 Q4	$895K	Sell	23,070 -604	-3%	-$24.4K	﹤0.01%	1121
2016 Q3	$993K	Buy	23,674 +329	+1%	+$13.5K	﹤0.01%	1032
2016 Q2	$864K	Sell	23,345 -190	-0.8%	-$7.45K	﹤0.01%	1083
2016 Q1	$901K	Sell	23,535 -235	-1%	-$9.13K	﹤0.01%	1029
2015 Q4	$1.2M	Buy	23,770 +100	+0.4%	+$4.94K	﹤0.01%	873
2015 Q3	$1.08M	Sell	23,670 -610	-3%	-$34.1K	﹤0.01%	921
2015 Q2	$1.42M	Sell	24,280 -50	-0.2%	-$2.86K	0.01%	846
2015 Q1	$1.34M	Sell	24,330 -200	-0.8%	-$10.8K	0.01%	881
2014 Q4	$1.23M	Sell	24,530 -280	-1%	-$13.7K	﹤0.01%	915
2014 Q3	$1.15M	Hold	24,810	–	–	﹤0.01%	932
2014 Q2	$1.08M	Hold	24,810	–	–	﹤0.01%	967
2014 Q1	$1.03M	Buy	24,810 +610	+3%	+$26.1K	﹤0.01%	963
2013 Q4	$897K	Hold	24,200	–	–	﹤0.01%	979
2013 Q3	$849K	Hold	24,200	–	–	﹤0.01%	961
2013 Q2	$700K	Buy	+24,200	New	+$688K	﹤0.01%	998

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

US Bancorp's PBE Position: Q1 2026 in Review

US Bancorp held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q1 2026 at 16,500 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1033.

US Bancorp first reported a position in PBE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.42M in Q2 2015. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

US Bancorp held 16,500 shares of Invesco Biotechnology & Genome ETF worth $1.31M as of Q1 2026.
US Bancorp left its Invesco Biotechnology & Genome ETF share count unchanged in Q1 2026.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #1033 holding.
US Bancorp first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and has held it in 52 quarters since.
US Bancorp's Invesco Biotechnology & Genome ETF position peaked at $1.42M in Q2 2015.
100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.